These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8157578

  • 1. Efficiency of oxetanocin-G, a novel nucleoside against the woodchuck hepatitis virus.
    Ikeda N, Kaneko S, Shimoda A, Inagaki Y, Unoura M, Okada M, Yonekawa Y, Takahashi K, Kobayashi K.
    J Antimicrob Chemother; 1994 Jan; 33(1):83-9. PubMed ID: 8157578
    [Abstract] [Full Text] [Related]

  • 2. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection.
    Tennant BC, Baldwin BH, Graham LA, Ascenzi MA, Hornbuckle WE, Rowland PH, Tochkov IA, Yeager AE, Erb HN, Colacino JM, Lopez C, Engelhardt JA, Bowsher RR, Richardson FC, Lewis W, Cote PJ, Korba BE, Gerin JL.
    Hepatology; 1998 Jul; 28(1):179-91. PubMed ID: 9657111
    [Abstract] [Full Text] [Related]

  • 3. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Cote PJ, Korba BE, Butler SD, George AL, Tochkov IA, Delaney WE, Xiong S, Gerin JL, Tennant BC.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [Abstract] [Full Text] [Related]

  • 4. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Asif G, Narayanasamy J, Butler SD, George AL, Hurwitz SJ, Schinazi RF, Chu CK, Cote PJ, Gerin JL, Tennant BC.
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3177-84. PubMed ID: 17606676
    [Abstract] [Full Text] [Related]

  • 5. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Jacob JR, Korba BE, Cote PJ, Toshkov I, Delaney WE, Gerin JL, Tennant BC.
    Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
    Daffis S, Balsitis S, Chamberlain J, Zheng J, Santos R, Rowe W, Ramakrishnan D, Pattabiraman D, Spurlock S, Chu R, Kang D, Mish M, Ramirez R, Li L, Li B, Ma S, Hung M, Voitenleitner C, Yon C, Suresh M, Menne S, Cote P, Delaney WE, Mackman R, Fletcher SP.
    Hepatology; 2021 Jan; 73(1):53-67. PubMed ID: 32246499
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
    Lu M, Hilken G, Yang D, Kemper T, Roggendorf M.
    J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
    [Abstract] [Full Text] [Related]

  • 12. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo.
    Korba BA, Xie H, Wright KN, Hornbuckle WE, Gerin JL, Tennant BC, Hostetler KY.
    Hepatology; 1996 May; 23(5):958-63. PubMed ID: 8621175
    [Abstract] [Full Text] [Related]

  • 13. Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection.
    Genovesi EV, Lamb L, Medina I, Taylor D, Seifer M, Innaimo S, Colonno RJ, Clark JM.
    Antiviral Res; 2000 Dec; 48(3):197-203. PubMed ID: 11164506
    [Abstract] [Full Text] [Related]

  • 14. Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks.
    Korba BE, Schinazi RF, Cote P, Tennant BC, Gerin JL.
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1757-60. PubMed ID: 10817750
    [Abstract] [Full Text] [Related]

  • 15. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
    Suresh M, Li B, Huang X, Korolowicz KE, Murreddu MG, Gudima SO, Menne S.
    Front Immunol; 2021 Jun; 12():745802. PubMed ID: 34671360
    [Abstract] [Full Text] [Related]

  • 16. Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology.
    Zahm FE, Bonino F, Giuseppetti R, Rapicetta M.
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):510-6. PubMed ID: 9836108
    [Abstract] [Full Text] [Related]

  • 17. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE, Cote P, Hornbuckle W, Tennant BC, Gerin JL.
    Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
    [Abstract] [Full Text] [Related]

  • 18. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
    Cullen JM, Smith SL, Davis MG, Dunn SE, Botteron C, Cecchi A, Linsey D, Linzey D, Frick L, Paff MT, Goulding A, Biron K.
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2076-82. PubMed ID: 9333028
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneous response for a mammalian hepadnavirus infection to acyclovir: drug-arrested intermediates of minus-strand viral DNA synthesis are enveloped and secreted from infected cells as virion-like particles.
    Tencza MG, Newbold JE.
    J Med Virol; 1997 Jan; 51(1):6-16. PubMed ID: 8986943
    [Abstract] [Full Text] [Related]

  • 20. The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir.
    Mason WS, Xu C, Low HC, Saputelli J, Aldrich CE, Scougall C, Grosse A, Colonno R, Litwin S, Jilbert AR.
    J Virol; 2009 Feb; 83(4):1778-89. PubMed ID: 19073743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.